Global Joint Pain Injections Market Report 2023: Key Players Focused on New Product Innovations to Meet Consumer Demand

DUBLIN, Nov. 21, 2023 /PRNewswire/ — The “Joint Pain Injections Global Market Report 2023” has been added to  ResearchAndMarkets.com’s offering.

The global joint pain injections market grew from $4.66 billion in 2022 to $5.13 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The joint pain injections market is expected to grow to $7.13 billion in 2027 at a CAGR of 8.6%.

The rise in the prevalence of arthritis and musculoskeletal disorders will propel the growth of the joint pain injections market. Musculoskeletal disorders are the biggest cause of disability worldwide, with low back pain being the single most common cause of impairment in 160 nations. Patients are taking injections for pain relief and inflammatory condition. For instance, in February 2021, according to the report published by WHO, approximately 1.71 billion people in the world are affected by musculoskeletal conditions and the number of people with musculoskeletal disorders is continuously growing due to population growth and aging. Similarly, in 2021, according to the report by Global RA Network, arthritis affects about 350 million people worldwide and increasing rapidly. Therefore, the rising prevalence of arthritis and musculoskeletal disorder drives the joint pain injections market.

New product development is a key trend gaining popularity in the joint pain injections market. Major companies operating in the join pain injections sector are focused on new product innovations to meet consumer demand and strengthen their position. In September 2021, Contura International Ltd., a UK-based manufacturer of innovative therapeutic hydrogels, launched Arthrosamid. Arthrosamid is an innovative hydrogel injection for knee osteoarthritis that uses non-biodegradable hydrogel technology, offers an alternative to existing treatments, satisfies a clinical need for a potent, long-lasting, secure, and minimally intrusive method of treating knee osteoarthritis pain (OA).

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.The forecasts are made after considering the major factors currently impacting the market. These include:The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.The impact of higher inflation in many countries and the resulting spike in interest rates.The continued but declining impact of COVID-19 on supply chains and consumption patterns.Market segmentations break down the market into sub markets.The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:

By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections; Platelet-Rich Plasma (PRP) Injections; Placental Tissue Matrix (PTM) Injections; Other Type Of InjectionSBy Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint TypesBy Distribution channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Company Profiles:

Seikagaku CorporationFlexion Therapeutics IncZimmer BiometSanofiAnika Therapeutics Inc

For more information about this report visit https://www.researchandmarkets.com/r/ca31pr

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-joint-pain-injections-market-report-2023-key-players-focused-on-new-product-innovations-to-meet-consumer-demand-301995115.html

SOURCE Research and Markets